Latest News & Updates
Breaking News
May 2, 2025
Simantini Singh Deo
Other trending news you may like to read
Recursion’s REC-4881 Shows Early Efficacy And Tolerability In Patients With Familial Adenomatous Polyposis
Recursion shares promising preliminary safety and efficacy results from REC-4881.
Vaibhavi M.
ARS Pharma Teams Up With ALK-Abelló To Bring neffy® Nasal Epinephrine To More U.S. Pediatricians
ARS Pharma Collaborates With ALK-Abelló To Expand neffy® in U.S.
Simantini Singh Deo
UK Approves Bavarian Nordic’s Chikungunya Vaccine For People Aged 12 And Up
UK MHRA grants marketing authorization for VIMKUNYA® to protect against the chikungunya virus for individuals aged 12 and up.
Simantini Singh Deo
AstraZeneca’s Breztri Shows Strong Efficacy In Phase III Asthma Trials, Meeting All Primary Endpoints
AstraZeneca announces positive top-line results in two Phase III trials through Breztri Aerosphere.
Vaibhavi M.
